Future FinTech Group Inc. (FTFT): Nasdaq/NYSE listing notice — Future FinTech receives NASDAQ delisting notice for late 10-K; expects to file today

Future FinTech Group Inc.

Received NASDAQ letter on April 18, 2023 for failure to timely file 2022 Form 10-K (Listing Rule 5250(c)(1)).
Has until June 20, 2023 to submit a compliance plan; possible extension to October 16, 2023.
Company states it expects to file the 2022 10-K with the SEC on April 19, 2023 to regain compliance.
No immediate effect on listing of FTFT common stock on NASDAQ Capital Market.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Future FinTech Group Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: late filing
Rules: 5250(c)(1)

Exact text from the filing

April 18, 2023, Future FinTech Group Inc. (the “Company”) received a notification letter from the NASDAQ Listing Qualifications (“NASDAQ”) stating the Company was not in compliance with NASDAQ Listing Rule 5250(c)(1), due to its failure to timely file its Annual Report on Form 10-K for the year ended December 31, 2022 (the “2022 10-K”). The NASDAQ notification letter provides the Company 60 calendar days from the date of the notification, or until June 20, 2023, to submit a plan to NASDAQ to regain compliance with the NASDAQ’s continued listing requirements. If the plan is accepted, NASDAQ can

View on SEC.gov

20 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Future FinTech Group Inc. filing history →

Source: SEC EDGAR

accession 0001213900-23-031043

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.